Can Medicaid Do More To Leverage 340B Drug Pricing? MACPAC May Try To Find Out
This article was originally published in The Pink Sheet Daily
Executive Summary
New Medicaid and CHIP Access and Payment Commission suggests that it should look into ways for Medicaid to benefit from the low drug prices 340B providers receive.